Less than half of patients ages 65 and older with metastatic non-small cell lung cancer received systemic treatment, according to a study published May 7 in JAMA Oncology. Researchers from Charleston-based Medical University of South Carolina, Memphis, Tenn.-based Baptist Cancer…
Author: Elizabeth Gregerson
Daraxonrasib, a drug that targets the genetic driver of most pancreatic cancers, extended clinical trial participants’ progression-free survival by a median of 8.5 months, according to a study published May 6 in The New England Journal of Medicine. Fifteen cancer…
Livonia, Mich.-based Trinity Health will invest $22.7 million in renovations at the Trinity Health Grand Rapids (Mich.) Richard J. Lacks Sr. Cancer Center. The cancer center will remain open during construction, which is expected to be completed in fall 2028,…
Wilmington, Del.-based ChristianaCare has appointed Deepak Vadehra, DO, chief of gastrointestinal oncology. Dr. Vadehra shared news of his appointment in a May 6 LinkedIn post. He was also appointed director of clinical trials and director of clinical research for solid…
Researchers from Rochester, Minn.-based Mayo Clinic and Stanford (Calif.) Medicine have developed a blood test capable of mapping cancer cell ecosystems to predict immunotherapy response, according to a study published May 6 in Nature. Certain cell ecosystems, or neighborhoods, are…
Advertisement
Seattle-based Fred Hutch Cancer Center has appointed Chris Li, MD, PhD, senior vice president and director of its public health sciences division. Dr. Li also serves as the Helen G. Edson Endowed Chair for Breast Cancer Research, according to a…
Patients are more likely to participate in colorectal cancer screening if they have a strong relationship with their healthcare provider, according to a study published April 24 in Cancer Medicine. Researchers from Renton, Wash.-based Providence surveyed 1,798 patients in racially…
Cleveland-based University Hospitals has received $12.5 million from Dee and Jimmy Haslam to fuel research of chronic lymphocytic leukemia and rare blood cancers. The gift will be used to advance new therapeutics into clinical trials through the Oxford-Harrington Rare Disease…
Hospitals in South Dakota and Vermont had the highest percentage of patients given the appropriate follow-up recommendation after colonoscopy in 2024, according to CMS data published Feb. 25. Hospitals in Nevada had the lowest percentage. CMS tracks the percentage of…
Meriden, Conn.-based MidState Medical Center, part of Hartford (Conn.) HealthCare, has received $4.2 million to expand cancer care services. The gift is the largest donation ever received by MidState Medical Center, according to a news release shared with Becker’s. Given…